Reference 2018-528

REF:           2018-528

Subject:       Knee Osteoarthritis and Viscosupplementation

 

Request:

  1. Does your organisation use/perform Viscosupplementation injections?
  2. How much has your organisation spent in the financial year 2017/18 on Viscosupplementation on each product out of the following list: Arhtrum H, Cingal, Durolane, Euflexxa, Fermathron, Orthovisc, Ostenil, Ostenil Plus, RenehaVis, Suplasyn, Synocrom, Synocrom Mini, Synolis, Monovisc, Synopsis, Synvisc (Hylan G-F20), Synvisc ONE (Hylan G-F20)
  3. Which brand(s) Viscosupplemenetation have been used in the financial year 2017/18 out of the following list: Arhtrum H, Cingal, Durolane, Euflexxa, Fermathron, Orthovisc, Ostenil, Ostenil Plus, RenehaVis, Suplasyn, Synocrom, Synocrom Mini, Synolis, Monovisc, Synopsis, Synvisc (Hylan G-F20), Synvisc ONE (Hylan G-F20)
  4. Which brand(s) Viscosupplementation do you have listed on the hospital formulary out of the following list: Arhtrum H, Cingal, Durolane, Euflexxa, Fermathron, Orthovisc, Ostenil, Ostenil Plus, RenehaVis, Suplasyn, Synocrom, Synocrom Mini, Synolis, Monovisc, Synopsis, Synvisc (Hylan G-F20), Synvisc ONE (Hylan G-F20)
  5. Which departments in your hospital use Viscosupplementation?
  6. What is your current pathway for knee osteoarthritis patients
  7. Do you have a community MSK service, if yes who is that contracted to?
  8. What is the current waiting list for Total Knee Replacement in your organisation for the financial year 2017/18
  9. Has the organisation incurred any fines for breach of the Total Knee Replacement waiting list in 2017/18

 

 

Response:

Please find information attached.

2018-528 – FOI Request – Knee Osteoarthritis and Viscosupplementation [114 kb] PDF

2018-528 – FOI Request – Knee Osteoarthritis and Viscosupplementation [13 kb] MS Excel